Fig. 1: Characterization of C-Mn3O4 NPs.
From: Redox nanomedicine ameliorates chronic kidney disease (CKD) by mitochondrial reconditioning in mice
a TEM image of C-Mn3O4 NPs shows the spherical shape of the nanoparticles with the monomodal distribution. Inset shows an HRTEM image of a single nanoparticle having a high crystalline structure with 0.311 nm interfringe distance corresponding to the (112) plane. The other inset shows the histogram for the size distribution of the nanoparticles having an average diameter of 5.58 ± 2.42 nm. b Experimental XRD peaks of the nanoparticle exactly match that of Mn3O4 hausmannite defined in the literature (JCPDS No. 24-0734). c FTIR spectra of C-Mn3O4 NPs, Mn3O4 NPs, and citrate. Perturbation at Mn–O stretching at 413, 514, 630 cm−1 (shaded gray) of Mn3O4 NPs and carboxylic groups at 1066, 1112, 1410, 1619 cm−1 (shaded yellow) of citrate confirms strong covalent binding between citrate and the nanoparticle.
